In summary, this study systematically elucidates HL4’s cardioprotective mechanism via the STAT3/HIF-1α axis, providing a robust scientific foundation for its clinical application and laying groundwork for developing STAT3-targeted therapies for myocardial ischemia-reperfusion injury. This evidence concerns the gene STAT3 and myocardial ischemia.